Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution

被引:30
|
作者
Komenaka I.K. [1 ,2 ]
Nodora J.N. [3 ]
Madlensky L. [3 ]
Winton L.M. [1 ]
Heberer M.A. [1 ]
Schwab R.B. [3 ]
Weitzel J.N. [4 ]
Martinez M.E. [3 ]
机构
[1] Maricopa Medical Center, Hogan Building, 2nd Floor, 2601 E Roosevelt Street, Phoenix, 85008, AZ
[2] Arizona Cancer Center, University of Arizona, Tucson, AZ
[3] University of California, San Diego, Moores Cancer Center, La Jolla, CA
[4] Division of Clinical Cancer Genetics, City of Hope, Duarte, CA
基金
美国国家卫生研究院;
关键词
Disparity; Genetic cancer risk assessment; Hispanic; Latina; Minority; Underinsured;
D O I
10.1007/s12687-015-0257-x
中图分类号
学科分类号
摘要
Some communities and populations lack access to genetic cancer risk assessment (GCRA) and testing. This is particularly evident in safety-net institutions, which serve a large segment of low-income, uninsured individuals. We describe the experience of a safety-net clinic with limited resources in providing GCRA and BRCA1/2 testing. We compared the proportion and characteristics of high-risk women who were offered and underwent GCRA and genetic testing. We also provide a description of the mutation profile for affected women. All 125 patients who were offered GCRA accepted to undergo GCRA. Of these, 72 % had a breast cancer diagnosis, 70 % were Hispanic, 52.8 % were non-English speakers, and 66 % did not have health insurance. Eighty four (67 %) were offered genetic testing and 81 (96 %) agreed. Hispanic women, those with no medical insurance, and those with a family history of breast cancer were significantly more likely to undergo testing (p > 0.01). Twelve of 81 (15 %) patients were found to have deleterious mutations, seven BRCA1, and five BRCA2. Our experience shows that it is possible to offer GCRA and genetic testing even in the setting of limited resources for these services. This is important given that a large majority of the low-income women in our study agreed to undergo counseling and testing. Our experience could serve as a model for similar low-resource safety-net health settings. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:177 / 183
页数:6
相关论文
共 50 条
  • [21] Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries
    Teixeira, Natalia
    Maistro, Simone
    Estevez Diz, Maria Del Pilar
    Mourits, Marian J.
    Oosterwijk, Jan C.
    Koike Folgueira, Maria Aparecida
    de Bock, Geertruida H.
    MATURITAS, 2017, 105 : 113 - 118
  • [22] PREDICTABILITY OF BRCA1/2 MUTATION STATUS IN OVARIAN CANCER PATIENTS: HOW TO SELECT WOMEN FOR GENETIC TESTING IN MIDDLE-INCOME COUNTRIES?
    Teixeira, N.
    Maistro, S.
    Diz, M. D. P. E.
    Mourits, M. J. E.
    Oosterwijk, J. C.
    Folgueira, M. A. K.
    de Bock, G. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 210 - 210
  • [23] Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
    Nguyen-Dumont, Tu
    Karpinski, Pawel
    Sasiadek, Maria M.
    Akopyan, Hayane
    Steen, Jason A.
    Theys, Derrick
    Hammet, Fleur
    Tsimiklis, Helen
    Park, Daniel J.
    Pope, Bernard J.
    Slezak, Ryszard
    Stembalska, Agnieszka
    Pesz, Karolina
    Kitsera, Nataliya
    Siekierzynska, Aleksandra
    Southey, Melissa C.
    Myszka, Aleksander
    GENETICS RESEARCH, 2020, 102
  • [25] Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: US Preventive Services Task Force Recommendation Statement
    Moyer, Virginia A.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) : 271 - 281
  • [26] Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2
    Bluman, LG
    Rimer, BK
    Berry, DA
    Borstelmann, N
    Iglehart, JD
    Regan, K
    Schildkraut, J
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 1040 - 1046
  • [27] BRCA1 and BRCA2 genetic testing in Hispanic patients:: Mutation prevalence and evaluation of the BRCAPRO risk assessment model
    Vogel, Kristen J.
    Atchley, Deann P.
    Erlichman, Julie
    Broglio, Kristine R.
    Ready, Kaylene J.
    Valero, Vicente
    Amos, Christopher I.
    Hortobagyi, Gabriel N.
    Lu, Karen H.
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4635 - 4641
  • [28] The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
    Matykiewicz, Jaroslaw
    Adamus-Bialek, Wioletta
    Wawszczak-Kasza, Monika
    Molasy, Bartosz
    Kolomanska, Magdalena
    Oblap, Ruslan
    Madej, Lukasz
    Koziel, Dorota
    Gluszek, Stanislaw
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [29] Predictors of psychological distress for women seeking BRCA1/BRCA2 genetic testing: Impact of family cancer history
    Lesniak, KT
    Keenan, LA
    Guarnaccia, CA
    Althaus, BW
    Ethington, GM
    Blum, JL
    PSYCHOSOMATIC MEDICINE, 2001, 63 (01): : 127 - 127
  • [30] Quality of life for women seeking BRCA1/2 genetic testing: Impact of family cancer history
    Lesniak, KT
    Keenan, LA
    Guarnaccia, CA
    Althaus, BW
    Ethington, GM
    Blum, JL
    PSYCHOSOMATIC MEDICINE, 2001, 63 (01): : 126 - 127